Department of Psychology, Queens College, CUNY, USA.
Department of Psychology, Queens College, CUNY, USA; CUNY Neuroscience Collaborative, CUNY Graduate Center, New York, NY, USA.
Pharmacol Biochem Behav. 2017 Dec;163:50-56. doi: 10.1016/j.pbb.2017.10.007. Epub 2017 Oct 16.
Nutritive (e.g., sucrose) and non-nutritive (e.g., saccharin) sweeteners stimulate intake in inbred mouse strains. BALB/c, SWR and C57BL/6 mice differ in the ability of dopamine (DA) D1 (SCH23390) and opioid (naltrexone) receptor antagonism to alter sucrose intake. Whereas SCH23390 comparably reduced cumulative sucrose intake in all three strains, naltrexone reduced cumulative sucrose intake maximally in C57/BL/6 mice, in intermediate fashion in BALB/c mice, but not in SWR mice. Whereas cumulative saccharin intake was reduced by DA D1 receptor antagonism in BALB/c and SWR mice, naltrexone was more potent in SWR relative to BALB/c mice. The present study first examined whether SCH23390 (50-1600nmol/kg) and naltrexone (0.01-5mg/kg) altered saccharin intake in C57BL/6 mice. Given that scopolamine (SCOP), a muscarinic cholinergic receptor antagonist, reduces sweet intake in outbred rats, a second experiment examined whether SCOP (0.1-10mg/kg) altered 0.2% saccharin and 10% sucrose intakes in BALB/c, SWR and C57BL/6 mice. Cumulative saccharin intake was significantly reduced by SCH23390 (200-1600nmol/kg; ID=175nmol/kg) and naltrexone (0.1-5mg/kg; ID>5mg/kg) in C57BL/6 mice. Cumulative sucrose intake was significantly reduced following SCOP in C57BL/6 (0.1-10mg/kg; ID=2.32mg/kg) and BALB/c (2.5-10mg/kg; ID=0.52mg/kg) mice. In contrast, SWR mice (ID=41.61mg/kg) only displayed transient (15min) reductions in sucrose intake following SCOP (2.5-10mg/kg). Cumulative saccharin intake was significantly reduced following SCOP in C57BL/6 and BALB/c mice (0.1-10mg/kg; ID<0.1mg/kg). In contrast, SWR mice (ID=2.28mg/kg) displayed smaller significant reductions in saccharin intake following SCOP (0.1-10mg/kg). These data indicate that although both nutritive and non-nutritive sweet intakes are governed by muscarinic cholinergic receptor signaling, this process is subject to murine genetic variance with greater sensitivity observed in C57BL/6 and BALB/c relative to SWR inbred mouse strains.
营养性(例如蔗糖)和非营养性(例如糖精)甜味剂刺激近交系小鼠的摄入。BALB/c、SWR 和 C57BL/6 小鼠之间多巴胺(DA)D1(SCH23390)和阿片受体拮抗作用改变蔗糖摄入的能力存在差异。虽然 SCH23390 可在所有三种品系中相似地降低累积蔗糖摄入量,但纳曲酮在 C57BL/6 小鼠中最大程度地降低了累积蔗糖摄入量,在 BALB/c 小鼠中以中间方式降低,但在 SWR 小鼠中不降低。虽然 DA D1 受体拮抗作用降低了 BALB/c 和 SWR 小鼠的累积蔗糖摄入量,但纳曲酮在 SWR 小鼠中的效力相对于 BALB/c 小鼠更高。本研究首先检查了 SCH23390(50-1600nmol/kg)和纳曲酮(0.01-5mg/kg)是否改变了 C57BL/6 小鼠的蔗糖摄入量。鉴于毒蕈碱乙酰胆碱能受体拮抗剂东莨菪碱可减少杂合大鼠的甜味摄入,第二项实验检查了东莨菪碱(0.1-10mg/kg)是否改变了 BALB/c、SWR 和 C57BL/6 小鼠的 0.2%蔗糖和 10%蔗糖摄入量。SCH23390(200-1600nmol/kg;ID=175nmol/kg)和纳曲酮(0.1-5mg/kg;ID>5mg/kg)显著降低了 C57BL/6 小鼠的累积蔗糖摄入量。C57BL/6(0.1-10mg/kg;ID=2.32mg/kg)和 BALB/c(2.5-10mg/kg;ID=0.52mg/kg)小鼠中 SCOP 后,累积蔗糖摄入量显著降低。相比之下,SWR 小鼠(ID=41.61mg/kg)仅在 SCOP(2.5-10mg/kg)后短暂(15 分钟)降低蔗糖摄入量。SCH23390(0.1-10mg/kg;ID<0.1mg/kg)后,C57BL/6 和 BALB/c 小鼠的累积蔗糖摄入量显著降低。相比之下,SWR 小鼠(ID=2.28mg/kg)在 SCOP(0.1-10mg/kg)后蔗糖摄入量的显著减少较小。这些数据表明,尽管营养性和非营养性甜味剂的摄入都受到毒蕈碱乙酰胆碱能受体信号的调节,但这一过程受到小鼠遗传变异的影响,与 SWR 近交系相比,C57BL/6 和 BALB/c 小鼠的敏感性更高。